Petra Riegerová, Jindřich Brejcha, Dagmar Bezděková, Tomáš Chum, Eva Mašínová, Nikola Čermáková, Saak V Ovsepian, Marek Cebecauer, Martin Štefl
Journal: Journal of Alzheimer's disease : JAD 2021;82(2):485-491
PMID: 34057078
Neuroblastoma cell line SH-SY5Y, due to its capacity to differentiate into neurons, easy handling, and low cost, is a common experimental model to study molecular events leading to Alzheimer's disease (AD). However, it is prevalently used in its undifferentiated state, which does not resemble neurons affected by the disease. Here, we show that the expression and localization of amyloid-β protein precursor (AβPP), one of the key molecules involved in AD pathogenesis, is dramatically altered in SH-SY5Y cells fully differentiated by combined treatment with retinoic acid and BDNF. We show that insufficient differentiation of SH-SY5Y cells results in AβPP mislocalization.
Full Text Sources:
Medical:
Other Literature Sources:
Full Text Sources:
Research Materials:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.